Joseph Adrian Tyndall's most recent trade in Axogen Inc. was a trade of 2,525 Common Stock done at an average price of $10.5 . Disclosure was reported to the exchange on Dec. 31, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Axogen Inc. | Joseph Adrian Tyndall | Director | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 31 Dec 2024 | 2,525 | 25,082 (0%) | 0% | 10.5 | 26,513 | Common Stock |
Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 22,557 (0%) | 0% | 0 | Common Stock | |
Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | |
Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 10,653 (0%) | 0% | - | Common Stock | |
Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 43,171 | 43,171 | - | - | Stock Option (right to purchase) |